Health Catalyst (HCAT) Stock Statistics & Valuation Metrics

Health Catalyst has a market cap or net worth of $256.97M. The enterprise value is $451.27M.

Health Catalyst has 70,210,650 shares outstanding. The number of shares has decreased by -2.65% in one year.

Health Catalyst’s return on equity (ROE) is -0.19 and return on invested capital (ROIC) is -9.13%.

The current PE Ratio of Health Catalyst is -6.12. Health Catalyst’s PEG ratio is 0.14.

In the last 12 months, Health Catalyst had revenue of 306.58M and earned -69.50M in profits. Earnings per share was -1.15.

In the last 12 months, operating cash flow was 14.56M and capital expenditures -16.40M, giving a free cash flow of -1.84M billion.

Health Catalyst pays an annual dividend of ―, resulting in a dividend yield of ―

Health Catalyst upcoming earnings date is May 7, 2025, TBA Not Confirmed.

Health Catalyst as a current ratio of 1.43, with Debt / Equity ratio of 68.75%

In the past 12 months, Health Catalyst has paid 333.00K in taxes.

Health Catalyst EV to EBITDA ratio is -15.75, with an EV/FCF ratio of 32.99.

Health Catalyst has $392.00M in cash and marketable securities with $251.09M in debt, giving a net cash position of -$140.91M billion.

Gross margin is 39.22%, with operating margin of -22.77%, and net profit margin of -22.67%.

The average price target for Health Catalyst is $8.04, which is 11.43% higher than the current price. The consensus rating is Moderate Buy